Endovia Health Sciences (EDVA) Selling, General & Administrative (2012 - 2024)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Selling, General & Administrative (2012 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.20 Bn | 133.35 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.39 Bn | 78.39 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 64.96 Bn | 59.78 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 57.62 Bn | 52.49 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.38 Bn | 35.28 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.14 Bn | 27.31 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.55 Bn | 26.38 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Endovia Health Sciences | 831,815.23 | 589,113.23 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 55,000.00 |
| Sep 30, 2023 | 3.05 Mn |
| Jun 30, 2023 | 2.92 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Sep 30, 2022 | 2.73 Mn |
| Jun 30, 2022 | 2.28 Mn |
| Mar 31, 2022 | 2.68 Mn |
| Sep 30, 2014 | 89,428.00 |
| Jun 30, 2014 | 84,886.00 |
| Mar 31, 2014 | 68,050.00 |
| Dec 31, 2013 | 65,717.00 |
| Sep 30, 2013 | 73,335.00 |
| Jun 30, 2013 | 47,487.00 |
| Mar 31, 2013 | 49,915.00 |
| Dec 31, 2012 | 42,838.00 |
| Sep 30, 2012 | 53,542.00 |
| Jun 30, 2012 | 35,086.00 |
| Mar 31, 2012 | 55,569.00 |